BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38881451)

  • 1. Looking for the philosopher's stone: Emerging approaches to target the hallmarks of aging in the skin.
    Lemaitre JM
    J Eur Acad Dermatol Venereol; 2024 Jul; 38 Suppl 4():5-14. PubMed ID: 38881451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics.
    Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
    FEBS J; 2023 Mar; 290(5):1362-1383. PubMed ID: 35015337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies.
    Khalil R; Diab-Assaf M; Lemaitre JM
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular senescence in bone.
    Farr JN; Khosla S
    Bone; 2019 Apr; 121():121-133. PubMed ID: 30659978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases.
    Lagoumtzi SM; Chondrogianni N
    Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of senescent cell secretomes to identify common and specific features of the different senescent phenotypes: a tool for developing new senotherapeutics.
    Oguma Y; Alessio N; Aprile D; Dezawa M; Peluso G; Di Bernardo G; Galderisi U
    Cell Commun Signal; 2023 Sep; 21(1):262. PubMed ID: 37770897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Senescent Cells in Cancer: Wanted or Unwanted Citizens.
    Niklander SE; Lambert DW; Hunter KD
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Senotherapeutics for mesenchymal stem cell senescence and rejuvenation.
    Wong PF; Dharmani M; Ramasamy TS
    Drug Discov Today; 2023 Jan; 28(1):103424. PubMed ID: 36332835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Senescence and the SASP: many therapeutic avenues.
    Birch J; Gil J
    Genes Dev; 2020 Dec; 34(23-24):1565-1576. PubMed ID: 33262144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Skin aging-cellular senescence : What is the future?].
    Scharffetter-Kochanek K; Wang Y; Makrantonaki E; Crisan D; Wlaschek M; Geiger H; Maity P
    Dermatologie (Heidelb); 2023 Sep; 74(9):645-656. PubMed ID: 37638987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bright and dark side of skin senescence. Could skin rejuvenation anti-senescence interventions become a "bright" new strategy for the prevention of age-related skin pathologies?
    Georgakopoulou EA; Valsamidi C; Veroutis D; Havaki S
    Mech Ageing Dev; 2021 Jan; 193():111409. PubMed ID: 33249190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Cellular Senescence with Senotherapeutics: Development of New Approaches for Skin Care.
    Thompson EL; Pitcher LE; Niedernhofer LJ; Robbins PD
    Plast Reconstr Surg; 2022 Oct; 150():12S-19S. PubMed ID: 36170431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxylipin biosynthesis reinforces cellular senescence and allows detection of senolysis.
    Wiley CD; Sharma R; Davis SS; Lopez-Dominguez JA; Mitchell KP; Wiley S; Alimirah F; Kim DE; Payne T; Rosko A; Aimontche E; Deshpande SM; Neri F; Kuehnemann C; Demaria M; Ramanathan A; Campisi J
    Cell Metab; 2021 Jun; 33(6):1124-1136.e5. PubMed ID: 33811820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of fracture healing by senescence-associated secretory phenotype (SASP): a narrative review of the current literature.
    Zhao S; Qiao Z; Pfeifer R; Pape HC; Mao K; Tang H; Meng B; Chen S; Liu H
    Eur J Med Res; 2024 Jan; 29(1):38. PubMed ID: 38195489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of ENPP5, a senescence-associated secretory phenotype factor, prevents skin aging.
    Takaya K; Kishi K
    Biogerontology; 2024 Jun; 25(3):529-542. PubMed ID: 38436793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic and scalable assessment of the senescence-associated secretory phenotype (SASP).
    Malaquin N; Rodier F
    Methods Cell Biol; 2024; 181():181-195. PubMed ID: 38302239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translating Senotherapeutic Interventions into the Clinic with Emerging Proteomic Technologies.
    Dey AK; Banarjee R; Boroumand M; Rutherford DV; Strassheim Q; Nyunt T; Olinger B; Basisty N
    Biology (Basel); 2023 Oct; 12(10):. PubMed ID: 37887011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Senescent Cells: Dual Implications on the Retinal Vascular System.
    Habibi-Kavashkohie MR; Scorza T; Oubaha M
    Cells; 2023 Sep; 12(19):. PubMed ID: 37830555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular senescence: a key therapeutic target in aging and diseases.
    Zhang L; Pitcher LE; Yousefzadeh MJ; Niedernhofer LJ; Robbins PD; Zhu Y
    J Clin Invest; 2022 Aug; 132(15):. PubMed ID: 35912854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype.
    Coppé JP; Rodier F; Patil CK; Freund A; Desprez PY; Campisi J
    J Biol Chem; 2011 Oct; 286(42):36396-403. PubMed ID: 21880712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.